India Budget: India's pharmaceutical industry, a global leader in volume, is poised to leverage its scale for greater international influence. The upcoming Union Budget 2026-27 presents a crucial opportunity to shift focus from low-margin generics to high-value segments like biologics and novel drug discovery.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/OEbw4tn
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» Budget 2026: Volume to value - How India can get a quiet superpower






0 comments:
Post a Comment